Emcure Pharmaceuticals Limited (BOM:544210)
India · Delayed Price · Currency is INR 1,873.40
-1.70 (-0.09%)
At close: Oct 28, 2026
Emcure Pharmaceuticals Market Cap
Emcure Pharmaceuticals has a market cap or net worth of 355.65 billion as of October 28, 2026. Its market cap has increased by 39.09% in one year.
Market Cap
355.65B
Enterprise Value
369.65B
Revenue
96.83B
Global Rank
n/a
Country Rank
n/a
PE Ratio
35.11
ChartMarket Cap Chart
Since July 10, 2024, Emcure Pharmaceuticals's market cap has increased from 256.95B to 355.65B, an increase of 38.41%. That is a compound annual growth rate of 15.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2026 | 355.65B | 37.49% |
| Dec 31, 2025 | 258.67B | -5.64% |
| Dec 31, 2024 | 274.13B | 6.68% |
| Jul 10, 2024 | 256.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Glenmark Pharmaceuticals | 628.12B |
| Alkem Laboratories | 601.41B |
| Ipca Laboratories | 491.83B |
| Gland Pharma | 469.15B |
| Ajanta Pharma | 422.41B |
| Emcure Pharmaceuticals | 337.67B |
| Wockhardt | 294.05B |
| Piramal Pharma | 259.43B |